{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:55:21Z","timestamp":1777859721804,"version":"3.51.4"},"reference-count":11,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Practice"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:p>In recent months, the coronavirus pandemic has significantly affected almost every industry in the United States, including health care and higher education. Faculty and students at colleges and schools of pharmacy nationwide have needed to quickly adapt as the delivery of curricula has shifted to primarily online format. Additionally, experiential rotations have been significantly affected as practice settings such as hospitals and outpatient clinics have limited students\u2019 interactions with patients or stopped allowing students on-site altogether. Our commentary will explore strategies that have been employed by experiential education coordinators and pharmacy preceptors from various settings to navigate experiential education during these difficult times while ensuring students successfully meet requirements for graduation. These will include descriptions of transitioning advanced pharmacy practice experiences (APPEs) to virtual format, how to safely involve students in the care of COVID-19 patients, and managing scheduling issues.<\/jats:p>","DOI":"10.1177\/0897190020977730","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T04:14:16Z","timestamp":1606968856000},"page":"7-10","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Strategies for Managing Pharmacy Experiential Education During COVID-19"],"prefix":"10.1177","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1182-6388","authenticated-orcid":false,"given":"Cynthia","family":"Moreau","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Nova Southeastern University College of Pharmacy, Fort Lauderdale, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Maravent","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Nova Southeastern University College of Pharmacy, Fort Lauderdale, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2161-1543","authenticated-orcid":false,"given":"Genevieve M.","family":"Hale","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Nova Southeastern University College of Pharmacy, Fort Lauderdale, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Joseph","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Nova Southeastern University College of Pharmacy, Fort Lauderdale, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"bibr1-0897190020977730","unstructured":"Accreditation Standards and Key Elements for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree (\u201cStandards 2016\u201d). Accreditation council for pharmacy education. Published 2015. Accessed November 23, 2020. https:\/\/www.acpe-accredit.org\/pdf\/Standards2016FINAL.pdf"},{"key":"bibr2-0897190020977730","unstructured":"Guidance for the Accreditation Standards and Key Elements for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree (\u201cGuidance for Standards 2016\u201d). Accreditation Council for Pharmacy Education. Published 2015. Accessed November 23, 2020. https:\/\/www.acpe-accredit.org\/pdf\/GuidanceforStandards2016FINAL.pdf"},{"key":"bibr3-0897190020977730","unstructured":"Medicare Telemedicine Health Care Provider Fact Sheet. Centers for Medicare & Medicaid Services (CMS). Published 2020. Accessed November 23, 2020. https:\/\/www.cms.gov\/newsroom\/fact-sheets\/medicare-telemedicine-health-care-provider-fact-sheet"},{"key":"bibr4-0897190020977730","unstructured":"Paavola A. 256 hospitals furloughing workers in response to COVID-19. Becker\u2019s Hospital Review. Published 2020. Accessed November 23, 2020. https:\/\/www.beckershospitalreview.com\/finance\/49-hospitals-furloughing-workers-in-response-to-covid-19.html"},{"key":"bibr5-0897190020977730","unstructured":"Marsh T. Live updates: which drugs are in shortage because of COVID-19? GoodRx. Published 2020. Accessed November 23, 2020. https:\/\/www.goodrx.com\/blog\/covid-19-drug-shortages-updates\/"},{"key":"bibr6-0897190020977730","unstructured":"US Food and Drug Administration. FDA advises patients on the use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19. Accessed November 23, 2020. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19\/"},{"key":"bibr7-0897190020977730","unstructured":"Murray S. New evidence concerning safety of ACE inhibitors, ARBs in COVID-19. Pharmacy Times. Published 2020. Accessed November 23, 2020. https:\/\/www.pharmacytimes.com\/news\/new-evidence-concerning-safety-of-ace-inhibitors-arbs-in-covid-19\/"},{"key":"bibr8-0897190020977730","unstructured":"National Institutes of Health. COVID-19 treatment guidelines. Accessed November 23, 2020. https:\/\/www.covid19treatmentguidelines.nih.gov\/introduction\/"},{"key":"bibr9-0897190020977730","unstructured":"Ientile G. Famotidine trial underway in NYC for COVID-19 treatment. Drug Topics. Published 2020. Accessed November 23, 2020. https:\/\/www.drugtopics.com\/latest\/famotidine-trial-underway-nyc-covid-19-treatment"},{"key":"bibr10-0897190020977730","unstructured":"US Department of Health & Human Services. HHS statements on authorizing licensed pharmacists to order and administer COVID-19 tests. Accessed November 23, 2020. https:\/\/www.hhs.gov\/about\/news\/2020\/04\/08\/hhs-statements-on-authorizing-licensed-pharmacists-to-order-and-administer-covid-19-tests.html"},{"key":"bibr11-0897190020977730","unstructured":"Coronavirus Disease 2019 (COVID-19) Cases & Deaths by County. Centers for Disease Control and Prevention. Published 2020. Accessed November 23, 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/cases-updates\/county-map.html?state=FL"}],"container-title":["Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190020977730","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0897190020977730","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190020977730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:36:24Z","timestamp":1777509384000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0897190020977730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1177\/0897190020977730"],"URL":"https:\/\/doi.org\/10.1177\/0897190020977730","relation":{},"ISSN":["0897-1900","1531-1937"],"issn-type":[{"value":"0897-1900","type":"print"},{"value":"1531-1937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,3]]}}}